Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...

At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

Other states like California have since banned such tools from being purchased with opioid settlement money. The current funding cycle has drawn criticism from groups that were not funded, and for the ...

The class eligible for settlement payments, broadly speaking, consists of nongovernment acute care hospitals that treated patients with an opioid-related condition between Jan. 1, 2009 ...

Activist Ryan Hampton sees a major flaw in the proposed $7.4 billion bankruptcy settlement reached by the OxyContin maker. While it's potentially one of the largest opioid settlements ever ...

In 2022, the state started receiving proceeds negotiated through the National Opioid Settlement with pharmaceutical companies. With $980 million due to come to Indiana over 18 years, the Indiana ...